Follow the Active Biotech AB stock price and the full management transaction log of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Active Biotech AB has recorded 1 public disclosures. Market capitalisation: €134.4m. The latest transaction was disclosed on 16 December 2025 (Purchase). Among the most active insiders: Erik Vahtola. Every trade is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Active Biotech AB es una empresa farmacéutica sueca centrada en el desarrollo de tratamientos para enfermedades graves. Se dirige principalmente a enfermedades autoinmunes y cáncer.